YahooOctober 21, 2026 at 12:51 PM NY6 Days Ago
Why This Pharma Pro Likes Johnson & Johnson, Eli Lilly, and Merck Stock
Despite rising interest rates and the uncertainty of midterm elections, Asad Haider of Goldman Sachs sees promise in Big Pharma and biotech.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
